The Effect of Switching to Maraviroc + Darunavir/Ritonavir Dual Therapy in Virologically Suppressed Patients on the Progression of Liver Fibrosis: Findings From a Randomized Study
No abstract available
Source: JAIDS Journal of Acquired Immune Deficiency Syndromes - Category: Infectious Diseases Tags: Letters to the Editor Source Type: research
More News: Infectious Diseases | Liver | Norvir | Prezista | Study | Urology & Nephrology | Virology